![Robert Jotte presents how Adagrasib shows improvement in PFS and ORR in previously treated patients – Sarah Cannon Research Institute](https://oncodaily.com/pub/uploads/2024/06/Jotte-e1719595611165-1280x960.jpg)
Photo of Robert Jotte from rockymountaincancercenters.com
Jul 1, 2024, 14:03
Robert Jotte presents how Adagrasib shows improvement in PFS and ORR in previously treated patients – Sarah Cannon Research Institute
Sarah Cannon Research Institute shared on LinkedIn:
“Significant advancements in NSCLC treatment! SCRI’s Dr. Robert Jotte presents how Adagrasib shows improvement in PFS and ORR over Docetaxel in previously treated patients. Watch his detailed discussion on ecancer.”